"There is a realization that emerging viruses are not going to go away," says virologist Michael Buchmeier of the Scripps Research Institute in La Jolla, California. The nation "has been complacent", he says. Now the pathogens "are staring us in the face".
Deadly microorganisms targeted for study include the Ebola, Marburg and Lassa fever viruses from Africa. There is also interest in other arenaviruses previously found in Latin America but now identified in California. West Nile virus and dengue fever viruses are also emerging as potential threats to public health. And there is growing official concern about bioterrorism involving agents such as anthrax and Bolivia's Machupo virus (see Nature 411, 232-235; 2001) .
Germ warfare: several labs dedicated to the study of emerging virulent pathogens are planned in the US.
Many researchers say the study of these pathogens has been hampered by a lack of academic facilities, as they must be housed in labs with a tough safety designation known as Biosafety Level4 (BSL-4).
Research is at present concentrated at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, and at a US Army base at Fort Detrick in Maryland. The National Institutes of Health (NIH) also has a small BSL-4 lab for antibiotic-resistant tuberculosis research in Bethesda, Maryland. And last year the Southwest Foundation for Biomedical Research in San Antonio, Texas, expanded its BSL-4 facilities. These had been restricted to a containment box with access through gloved arms, and now have a walk-in laboratory where scientists wear protective suits.
These facilities were previously the only BSL-4 laboratories in the United States. But in August the University of Texas Medical Branch (UTMB) at Galveston will start building a $10.5-million facility that should be finished by late next year. Last December, the UTMB recruited C. J. Peters, the CDC's head of the Special Pathogens Branch, to run the BSL-4lab. And last month, the NIH certified the university's safety plans.
The California Department of Health Services and the University of California, Davis, are meeting regularly to plan another facility, which they hope to build for an estimated $50 million. Current discussions envisage that the state will fund construction of the BSL-4 laboratory on the Davis campus, with the university operating the lab.
At Texas Tech University in Lubbock, meanwhile, officials are planning a $98.5-million research facility that would include a BSL-4lab at the decommissioned Reese Air Force base outside Lubbock. Last month, Texas Tech's board of regents voted to seek $4 million for design plans for the facility, which would focus on bioterrorism.
And the University ofNew Mexico in Albuquerque is exploring funding possibilities for a BSL-4lab to extend its research on hantaviruses, says biologist Terry Yates, the university's new vice-president for research.
Both Texas Tech and New Mexico may look to Congress for funding for their facilities, officials say. In 1995, Texas A and Mat College Station failed to secure funds from Congress for a BSL-4lab. Officials there say they remain interested, but are not actively planning a facility. But attempts by other universities to get congressional funding may reinvigorate Texas A and M's plans.
